US20030022863A1 - Antiadhesive carbohydrates - Google Patents
Antiadhesive carbohydrates Download PDFInfo
- Publication number
- US20030022863A1 US20030022863A1 US10/182,739 US18273902A US2003022863A1 US 20030022863 A1 US20030022863 A1 US 20030022863A1 US 18273902 A US18273902 A US 18273902A US 2003022863 A1 US2003022863 A1 US 2003022863A1
- Authority
- US
- United States
- Prior art keywords
- carbohydrates
- antiadhesive
- carbohydrate
- uronic acid
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001720 carbohydrates Chemical class 0.000 title claims abstract description 234
- 235000014633 carbohydrates Nutrition 0.000 title claims abstract description 206
- 230000000181 anti-adherent effect Effects 0.000 title claims description 98
- 239000002253 acid Substances 0.000 claims abstract description 69
- 238000002360 preparation method Methods 0.000 claims abstract description 31
- 235000005911 diet Nutrition 0.000 claims abstract description 16
- 230000000378 dietary effect Effects 0.000 claims abstract description 16
- 239000000126 substance Substances 0.000 claims abstract description 14
- 241000124008 Mammalia Species 0.000 claims abstract description 9
- 230000001717 pathogenic effect Effects 0.000 claims abstract description 5
- 230000000903 blocking effect Effects 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 27
- 235000013406 prebiotics Nutrition 0.000 claims description 24
- 238000006116 polymerization reaction Methods 0.000 claims description 13
- 244000052769 pathogen Species 0.000 claims description 12
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 230000007935 neutral effect Effects 0.000 claims description 7
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 5
- 150000004676 glycans Chemical class 0.000 claims description 5
- 229920001542 oligosaccharide Polymers 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- 208000015181 infectious disease Diseases 0.000 claims description 4
- 210000002429 large intestine Anatomy 0.000 claims description 4
- 150000002482 oligosaccharides Chemical class 0.000 claims description 4
- 230000000241 respiratory effect Effects 0.000 claims description 4
- 239000000969 carrier Substances 0.000 claims description 3
- 150000001768 cations Chemical class 0.000 claims description 3
- 230000032050 esterification Effects 0.000 claims description 3
- 238000005886 esterification reaction Methods 0.000 claims description 3
- 229910001385 heavy metal Inorganic materials 0.000 claims description 3
- 239000003053 toxin Substances 0.000 claims description 3
- 231100000765 toxin Toxicity 0.000 claims description 3
- 108700012359 toxins Proteins 0.000 claims description 3
- PZUPAGRIHCRVKN-UHFFFAOYSA-N 5-[5-[3,4-dihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]-5-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound OCC1OC(O)C(O)C(O)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(COC4C(C(O)C(O)CO4)O)O3)O)C(COC3C(C(O)C(O)CO3)O)O2)O)C(COC2C(C(O)C(O)CO2)O)O1 PZUPAGRIHCRVKN-UHFFFAOYSA-N 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 235000013619 trace mineral Nutrition 0.000 claims description 2
- 239000011573 trace mineral Substances 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 239000000306 component Substances 0.000 claims 9
- 235000012041 food component Nutrition 0.000 claims 2
- 239000005428 food component Substances 0.000 claims 1
- 239000005417 food ingredient Substances 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 description 17
- 230000007017 scission Effects 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 16
- 229920001277 pectin Polymers 0.000 description 14
- 239000001814 pectin Substances 0.000 description 14
- 235000010987 pectin Nutrition 0.000 description 14
- 230000002255 enzymatic effect Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 6
- 230000001747 exhibiting effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 239000000872 buffer Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 229920001202 Inulin Polymers 0.000 description 3
- 108010029182 Pectin lyase Proteins 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- -1 barium salt) Chemical class 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 3
- 150000003271 galactooligosaccharides Chemical class 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 3
- 229940029339 inulin Drugs 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 230000011987 methylation Effects 0.000 description 3
- 238000007069 methylation reaction Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 229920000189 Arabinogalactan Polymers 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 229920000926 Galactomannan Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 108090000856 Lyases Proteins 0.000 description 2
- 102000004317 Lyases Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 2
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 235000019312 arabinogalactan Nutrition 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229940097043 glucuronic acid Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IAJILQKETJEXLJ-STGXQOJASA-N (2s,3s,4r,5s)-2,3,4,5-tetrahydroxy-6-oxohexanoic acid Chemical compound O=C[C@@H](O)[C@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-STGXQOJASA-N 0.000 description 1
- AQFATCCHOXBYNK-UHFFFAOYSA-N 2-piperidin-1-ium-1-ylethyl 1-cyclohexylcyclohexane-1-carboxylate;chloride Chemical compound [Cl-].C1CCCCC1(C1CCCCC1)C(=O)OCC[NH+]1CCCCC1 AQFATCCHOXBYNK-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- AVGPOAXYRRIZMM-UHFFFAOYSA-N D-Apiose Natural products OCC(O)(CO)C(O)C=O AVGPOAXYRRIZMM-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-BZINKQHNSA-N D-Guluronic Acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-BZINKQHNSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-LJJLCWGRSA-N D-apiofuranose Chemical compound OC[C@@]1(O)COC(O)[C@@H]1O ASNHGEVAWNWCRQ-LJJLCWGRSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N D-apiofuranose Natural products OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
- VQUZNVATTCZTQO-UHFFFAOYSA-N D-xyluronic acid Natural products O=CC(O)C(O)C(O)C(O)=O VQUZNVATTCZTQO-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 244000141359 Malus pumila Species 0.000 description 1
- VQUZNVATTCZTQO-HZLVTQRSSA-N O=C[C@H](O)[C@H](O)[C@H](O)C(O)=O Chemical compound O=C[C@H](O)[C@H](O)[C@H](O)C(O)=O VQUZNVATTCZTQO-HZLVTQRSSA-N 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 159000000009 barium salts Chemical class 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000007068 beta-elimination reaction Methods 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 235000021218 carrot soup Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 235000020197 coconut milk Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- IAJILQKETJEXLJ-LECHCGJUSA-N iduronic acid Chemical compound O=C[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-LECHCGJUSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000000178 monomer Chemical group 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 238000002103 osmometry Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 108010087558 pectate lyase Proteins 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 108010004131 poly(beta-D-mannuronate) lyase Proteins 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/231—Pectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Definitions
- the prebiotic carbohydrates/saccharides, which constitute the carbohydrate component A have another structure than the prebiotic carbohydrates/saccharides, which constitute the carbohydrate component B. Further preferred are at least 80 wt-% of the prebiotic carbohydrates/saccharides of the carbohydrate component A and B, namely those which favor lactic acid bacteria and/or are bifidogenous.
- the weight percentage of the carbohydrate component A is in this case preferably larger than the weight percentage of the carbohydrate component B.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Dispersion Chemistry (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dental Preparations (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Steroid Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/313,674 US7759324B2 (en) | 2000-02-16 | 2005-12-22 | Antiadhesive carbohydrates |
| US11/511,500 US7919479B2 (en) | 2000-02-16 | 2006-08-29 | Antiadhesive carbohydrates |
| US13/038,741 US20110152168A1 (en) | 2000-02-16 | 2011-03-02 | Antiadhesive carbohydrates |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10006989.4 | 2000-02-16 | ||
| DE10006989A DE10006989A1 (de) | 2000-02-16 | 2000-02-16 | Antiadhäsive Kohlenhydratmischung |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/313,674 Continuation US7759324B2 (en) | 2000-02-16 | 2005-12-22 | Antiadhesive carbohydrates |
| US11/511,500 Continuation US7919479B2 (en) | 2000-02-16 | 2006-08-29 | Antiadhesive carbohydrates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20030022863A1 true US20030022863A1 (en) | 2003-01-30 |
Family
ID=7631150
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/182,739 Abandoned US20030022863A1 (en) | 2000-02-16 | 2001-02-16 | Antiadhesive carbohydrates |
| US11/313,674 Expired - Fee Related US7759324B2 (en) | 2000-02-16 | 2005-12-22 | Antiadhesive carbohydrates |
| US11/511,500 Expired - Fee Related US7919479B2 (en) | 2000-02-16 | 2006-08-29 | Antiadhesive carbohydrates |
| US13/038,741 Abandoned US20110152168A1 (en) | 2000-02-16 | 2011-03-02 | Antiadhesive carbohydrates |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/313,674 Expired - Fee Related US7759324B2 (en) | 2000-02-16 | 2005-12-22 | Antiadhesive carbohydrates |
| US11/511,500 Expired - Fee Related US7919479B2 (en) | 2000-02-16 | 2006-08-29 | Antiadhesive carbohydrates |
| US13/038,741 Abandoned US20110152168A1 (en) | 2000-02-16 | 2011-03-02 | Antiadhesive carbohydrates |
Country Status (26)
| Country | Link |
|---|---|
| US (4) | US20030022863A1 (pl) |
| EP (3) | EP2305270A1 (pl) |
| JP (1) | JP4965043B2 (pl) |
| CN (2) | CN101057853B (pl) |
| AT (1) | ATE517628T1 (pl) |
| AU (2) | AU4644101A (pl) |
| BR (1) | BR0108354B1 (pl) |
| CA (2) | CA2400244C (pl) |
| CY (1) | CY1111968T1 (pl) |
| CZ (1) | CZ20022702A3 (pl) |
| DE (1) | DE10006989A1 (pl) |
| DK (1) | DK1267891T3 (pl) |
| ES (1) | ES2370478T3 (pl) |
| HK (1) | HK1053986A1 (pl) |
| HU (1) | HUP0300409A3 (pl) |
| IL (1) | IL151274A (pl) |
| MX (1) | MXPA02007970A (pl) |
| NO (2) | NO331735B1 (pl) |
| NZ (1) | NZ520642A (pl) |
| PL (1) | PL204585B1 (pl) |
| PT (1) | PT1267891E (pl) |
| RU (1) | RU2267324C2 (pl) |
| SK (1) | SK288087B6 (pl) |
| TR (1) | TR200202008T2 (pl) |
| WO (1) | WO2001060378A2 (pl) |
| ZA (1) | ZA200206177B (pl) |
Cited By (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005039597A2 (en) * | 2003-10-24 | 2005-05-06 | N.V. Nutricia | Immunemodulating oligosaccharides |
| EP1629850A1 (en) | 2004-08-24 | 2006-03-01 | Nutricia N.V. | Nutritional composition comprising indigestible oligosaccharides |
| US20060110516A1 (en) * | 2002-08-30 | 2006-05-25 | Holtus Maria F | Foaming ingredient and products containing the ingredient |
| EP1714562A1 (en) * | 2005-04-22 | 2006-10-25 | N.V. Nutricia | Process for drying uronic acid oligosaccharides |
| GB2430881A (en) * | 2005-10-06 | 2007-04-11 | Ntnu Technology Transfer As | Use of an oligoelectrolyte polyol to treat mucosal hyperviscosity |
| WO2007046697A1 (en) * | 2005-10-21 | 2007-04-26 | N.V. Nutricia | Method for treating and/or preventing infections in infants delivered via caesarean section |
| WO2007067033A1 (en) * | 2005-12-06 | 2007-06-14 | N.V. Nutricia | Composition containing oligosaccharides for the treatment/ prevention of infections |
| US20080064656A1 (en) * | 2004-06-22 | 2008-03-13 | N,V, Nutricia | Improvement of intestinal barrier integrity |
| US20080171720A1 (en) * | 2005-04-21 | 2008-07-17 | N.V. Nutricia | Nutritional Supplement For Hiv Patients |
| US20080207559A1 (en) * | 1998-08-11 | 2008-08-28 | N.V. Nutricia | Carbohydrates mixture |
| US20090082249A1 (en) * | 2005-04-21 | 2009-03-26 | N.V. Nutricia | Nutritional supplement for a category of hiv patients |
| US20100069320A1 (en) * | 2004-05-17 | 2010-03-18 | N.V. Nutricia | Synergism of gos and polyfructose |
| US20100152122A1 (en) * | 2007-04-12 | 2010-06-17 | Ntnu Technology Transfer As | Oligo-guluronate and galacturonate compositions |
| US20100167982A1 (en) * | 2004-06-22 | 2010-07-01 | N.V. Nutricia | Barrier integrity in hiv patients |
| US20100305062A1 (en) * | 2007-11-27 | 2010-12-02 | Algipharma Ipr As | Use of alginate oligomers in combating biofilms |
| US20110008485A1 (en) * | 2007-12-05 | 2011-01-13 | N.V. Nutricia | Protein-dense micellar casein-based liquid enteral nutritional composition |
| US20110021421A1 (en) * | 2007-12-05 | 2011-01-27 | N.V. Nutricia | Liquid enteral nutritional composition with a low specific protein volume |
| US20110038982A1 (en) * | 2007-12-05 | 2011-02-17 | N.V. Nutricia | High energy liquid enteral nutritional composition |
| US20110046048A1 (en) * | 2008-03-12 | 2011-02-24 | N.V. Nutricia | High protein liquid enteral nutritional composition |
| US20110077189A1 (en) * | 2008-02-01 | 2011-03-31 | N.V. Nutricia | Composition for stimulating natural killer cell activity |
| US20110150851A1 (en) * | 2008-06-30 | 2011-06-23 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
| US20110236500A1 (en) * | 2005-04-21 | 2011-09-29 | N.V. Nutricia | Nutritional supplement with colostrum and epa or dha or gla |
| US8529890B2 (en) | 2009-03-23 | 2013-09-10 | Ntnu Technology Transfer As | Composition for the administration of polymeric drugs |
| US8815831B2 (en) | 2009-06-03 | 2014-08-26 | Algipharma As | Treatment of Acinetobacter with alginate oligomers and antibiotics |
| US8987215B2 (en) | 2009-03-23 | 2015-03-24 | Ntnu Technology Transfer As | Composition for use in gene therapy |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10057976B4 (de) | 2000-11-22 | 2005-02-03 | Südzucker AG Mannheim/Ochsenfurt | Verfahren zur Herstellung von Pektinhydrolyseprodukten |
| FR2831819B1 (fr) * | 2001-11-08 | 2004-09-03 | Rocher Yves Biolog Vegetale | Utilisation d'oligosaccharides dans des compositions cosmetiques ou dermatologiques pour stimuler l'adhesion de keratinocytes sur les proteines majeures de la jonction dermo-epidermique |
| EP1634599A1 (en) | 2004-08-20 | 2006-03-15 | N.V. Nutricia | Iimmune stimulatory infant nutrition |
| EP1745705A1 (en) * | 2005-07-20 | 2007-01-24 | N.V. Nutricia | Process for preparing uronic acid oligosaccharides by extrusion |
| WO2009075564A1 (en) | 2007-12-10 | 2009-06-18 | N.V. Nutricia | Paediatric fibre mixture |
| EP2130440A1 (en) * | 2008-06-06 | 2009-12-09 | N.V. Nutricia | Inhibiting E. sakazakii growth |
| WO2010002242A1 (en) | 2008-07-02 | 2010-01-07 | N.V. Nutricia | Nutritional composition for improving muscle function and daily activity |
| WO2010140877A1 (en) | 2009-06-05 | 2010-12-09 | N.V. Nutricia | Liquid enteral nutritional composition with a low monovalent metal ion content |
| WO2011078654A1 (en) | 2009-12-24 | 2011-06-30 | N.V. Nutricia | Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis |
| WO2011112075A1 (en) | 2010-03-11 | 2011-09-15 | N.V. Nutricia | Controlling the texture of high-protein nutritional compositions comprising micellar casein |
| WO2012005568A1 (en) | 2010-07-07 | 2012-01-12 | N.V. Nutricia | Nutritional composition for the stimulation of muscle protein synthesis |
| WO2013012313A1 (en) | 2011-07-18 | 2013-01-24 | N.V. Nutricia | Use of a nucleotide for improving the heat stability of an aqueous micellar casein composition |
| WO2013117234A1 (en) | 2012-02-10 | 2013-08-15 | N.V. Nutricia | Maternal composition for enhancing immune system |
| ES2564507T3 (es) | 2012-02-10 | 2016-03-23 | N.V. Nutricia | Complemento materno para mejorar el sistema inmunitario de un lactante |
| WO2013129912A1 (en) | 2012-02-28 | 2013-09-06 | N.V. Nutricia | Energy-rich liquid nutritional composition having improved organoleptic properties |
| US9314494B2 (en) | 2012-05-25 | 2016-04-19 | The United States Of America, As Represented By The Secretary Of Agriculture | Cranberry xyloglucan oligosaccharide composition |
| BR112015030767B1 (pt) | 2013-06-10 | 2021-03-30 | N.V. Nutricia | Uso de uma composição |
| MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| EP3370748B1 (en) | 2015-11-03 | 2022-06-08 | The Brigham and Women's Hospital, Inc. | Therapeutic microbiota for the treatment and/or prevention of food allergy |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4619831A (en) * | 1984-06-04 | 1986-10-28 | Warner-Lambert Company | Dietary fiber composition and process of manufacture |
| US5952308A (en) * | 1991-07-29 | 1999-09-14 | Pola Chemical Industries Inc. | Mineral absorption promoting agent |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3046414A1 (de) * | 1980-12-10 | 1982-07-29 | Thiele Forschung Diaetetische | "nahrungs- oder heilmittel" |
| DE4330773A1 (de) | 1993-09-10 | 1995-03-16 | Laevosan Gmbh & Co Kg | Blockierung der Anlagerung von Keimen an menschliche Zellen |
| DE19503423A1 (de) * | 1995-02-03 | 1996-08-08 | Beiersdorf Ag | Antiadhäsive Wirkstoffe |
| AU1735097A (en) * | 1996-03-15 | 1997-10-01 | Takara Shuzo Co., Ltd. | A product of heat treatment of uronic acid, food, drink or drug including the product |
| EP1172041B2 (en) * | 1996-08-09 | 2009-09-02 | Mannatech, Inc. | Compositions of plant carbohydrates as dietary supplements |
| JPH10226701A (ja) * | 1997-02-14 | 1998-08-25 | Yoko Takenaka | オリゴガラクツロン酸含有抗菌組成物及びその製造方法 |
| EP1094824B1 (en) * | 1998-06-10 | 2006-04-05 | Albert B. Crum | Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system |
| DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
-
2000
- 2000-02-16 DE DE10006989A patent/DE10006989A1/de not_active Withdrawn
-
2001
- 2001-02-16 JP JP2001559474A patent/JP4965043B2/ja not_active Expired - Fee Related
- 2001-02-16 CN CN200710100849.6A patent/CN101057853B/zh not_active Expired - Fee Related
- 2001-02-16 AT AT01919291T patent/ATE517628T1/de active
- 2001-02-16 BR BRPI0108354-6A patent/BR0108354B1/pt not_active IP Right Cessation
- 2001-02-16 EP EP10183673A patent/EP2305270A1/de not_active Withdrawn
- 2001-02-16 PT PT01919291T patent/PT1267891E/pt unknown
- 2001-02-16 TR TR2002/02008T patent/TR200202008T2/xx unknown
- 2001-02-16 CZ CZ20022702A patent/CZ20022702A3/cs unknown
- 2001-02-16 CN CN01805223A patent/CN1404395A/zh active Pending
- 2001-02-16 ES ES01919291T patent/ES2370478T3/es not_active Expired - Lifetime
- 2001-02-16 CA CA2400244A patent/CA2400244C/en not_active Expired - Fee Related
- 2001-02-16 EP EP01919291A patent/EP1267891B1/de not_active Expired - Lifetime
- 2001-02-16 NZ NZ520642A patent/NZ520642A/en not_active IP Right Cessation
- 2001-02-16 PL PL363272A patent/PL204585B1/pl unknown
- 2001-02-16 US US10/182,739 patent/US20030022863A1/en not_active Abandoned
- 2001-02-16 RU RU2002124589/15A patent/RU2267324C2/ru not_active IP Right Cessation
- 2001-02-16 AU AU4644101A patent/AU4644101A/xx active Pending
- 2001-02-16 WO PCT/EP2001/001753 patent/WO2001060378A2/de active IP Right Grant
- 2001-02-16 SK SK1168-2002A patent/SK288087B6/sk not_active IP Right Cessation
- 2001-02-16 HU HU0300409A patent/HUP0300409A3/hu not_active IP Right Cessation
- 2001-02-16 AU AU2001246441A patent/AU2001246441B2/en not_active Ceased
- 2001-02-16 MX MXPA02007970A patent/MXPA02007970A/es active IP Right Grant
- 2001-02-16 DK DK01919291.3T patent/DK1267891T3/da active
- 2001-02-16 EP EP10181824A patent/EP2298325A1/de not_active Withdrawn
- 2001-02-16 CA CA2765218A patent/CA2765218A1/en not_active Abandoned
-
2002
- 2002-08-02 ZA ZA200206177A patent/ZA200206177B/en unknown
- 2002-08-14 NO NO20023846A patent/NO331735B1/no not_active IP Right Cessation
- 2002-08-15 IL IL151274A patent/IL151274A/en not_active IP Right Cessation
-
2003
- 2003-09-06 HK HK03106357.1A patent/HK1053986A1/zh unknown
-
2005
- 2005-12-22 US US11/313,674 patent/US7759324B2/en not_active Expired - Fee Related
-
2006
- 2006-08-29 US US11/511,500 patent/US7919479B2/en not_active Expired - Fee Related
-
2011
- 2011-03-02 US US13/038,741 patent/US20110152168A1/en not_active Abandoned
- 2011-07-14 NO NO20111024A patent/NO20111024L/no not_active Application Discontinuation
- 2011-10-27 CY CY20111101027T patent/CY1111968T1/el unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4619831A (en) * | 1984-06-04 | 1986-10-28 | Warner-Lambert Company | Dietary fiber composition and process of manufacture |
| US5952308A (en) * | 1991-07-29 | 1999-09-14 | Pola Chemical Industries Inc. | Mineral absorption promoting agent |
Cited By (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8277836B2 (en) | 1998-08-11 | 2012-10-02 | N.V. Nutricia | Carbohydrates mixture |
| US20080207559A1 (en) * | 1998-08-11 | 2008-08-28 | N.V. Nutricia | Carbohydrates mixture |
| US9763466B2 (en) | 1998-08-11 | 2017-09-19 | N.V. Nutricia | Carbohydrates mixture |
| US8580295B2 (en) | 1998-08-11 | 2013-11-12 | N.V. Nutricia | Carbohydrates mixture |
| US20100016214A1 (en) * | 1998-08-11 | 2010-01-21 | N.V. Nutricia | Carbohydrates mixture |
| US20060110516A1 (en) * | 2002-08-30 | 2006-05-25 | Holtus Maria F | Foaming ingredient and products containing the ingredient |
| EP2305269A3 (en) * | 2003-10-24 | 2011-07-13 | N.V. Nutricia | Immunemodulating oligosaccharides |
| WO2005039597A2 (en) * | 2003-10-24 | 2005-05-06 | N.V. Nutricia | Immunemodulating oligosaccharides |
| EP1721612A2 (en) * | 2003-10-24 | 2006-11-15 | N.V. Nutricia | Immunemodulating oligosaccharides |
| EP1935425A3 (en) * | 2003-10-24 | 2008-09-03 | N.V. Nutricia | Immunemodulating oligosaccharides for the treatment and/or prevention of chronic obstructive pulmonary disease (COPD) |
| EP2123282A3 (en) * | 2003-10-24 | 2010-01-20 | N.V. Nutricia | Immunemodulating oligosaccharides |
| US20070098762A1 (en) * | 2003-10-24 | 2007-05-03 | N.V. Nutricia | Immunemodulating oligosaccharides |
| EP1721612A3 (en) * | 2003-10-24 | 2007-05-09 | N.V. Nutricia | Immunemodulating oligosaccharides |
| EP1911453A3 (en) * | 2003-10-24 | 2008-09-03 | N.V. Nutricia | Immunemodulating oligosaccharides |
| WO2005039597A3 (en) * | 2003-10-24 | 2005-07-14 | Nutricia Nv | Immunemodulating oligosaccharides |
| EP1733730A3 (en) * | 2003-10-24 | 2006-12-27 | N.V. Nutricia | Immunemodulating oligosaccharides |
| EP2223691A1 (en) * | 2003-10-24 | 2010-09-01 | N.V. Nutricia | Immunemodulating oligosaccharides |
| AU2004283628B2 (en) * | 2003-10-24 | 2010-07-22 | N.V. Nutricia | Immunemodulating oligosaccharides |
| US8557794B2 (en) * | 2003-10-24 | 2013-10-15 | N.V. Nutricia | Immunemodulating oligosaccharides |
| US20100069320A1 (en) * | 2004-05-17 | 2010-03-18 | N.V. Nutricia | Synergism of gos and polyfructose |
| US10426791B2 (en) | 2004-05-17 | 2019-10-01 | N.V. Nutricia | Synergism of GOS and polyfructose |
| US10499676B2 (en) | 2004-06-06 | 2019-12-10 | N.V. Nutricia | Intestinal barrier integrity |
| US9084433B2 (en) | 2004-06-06 | 2015-07-21 | N. V. Nutricia | Intestinal barrier integrity |
| US8252769B2 (en) | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
| US11076623B2 (en) | 2004-06-22 | 2021-08-03 | N.V. Nutricia | Intestinal barrier integrity |
| US20080064656A1 (en) * | 2004-06-22 | 2008-03-13 | N,V, Nutricia | Improvement of intestinal barrier integrity |
| US20100167982A1 (en) * | 2004-06-22 | 2010-07-01 | N.V. Nutricia | Barrier integrity in hiv patients |
| US20080124323A1 (en) * | 2004-08-24 | 2008-05-29 | N.V. Nutricia | Nutritional Composition Comprising Indigestible Oligosaccharides |
| US9566291B2 (en) | 2004-08-24 | 2017-02-14 | N.V. Nutricia | Nutritional composition comprising indigestible oligosaccharides |
| EP1629850A1 (en) | 2004-08-24 | 2006-03-01 | Nutricia N.V. | Nutritional composition comprising indigestible oligosaccharides |
| EP2359858B1 (en) | 2004-08-24 | 2022-08-10 | N.V. Nutricia | Nutritional composition comprising indigestible oligosaccharides |
| EP1784222B1 (en) * | 2004-08-24 | 2018-10-10 | N.V. Nutricia | Nutritional composition comprising indigestible oligosaccharides |
| US8277835B2 (en) | 2004-08-24 | 2012-10-02 | N. V. Nutricia | Nutritional composition comprising immunoglobulins and oligosaccharides |
| US20070274983A1 (en) * | 2004-08-24 | 2007-11-29 | N.V. Nutricia | Nutritional Composition Comprising Immunoglobulins and Oligosaccharides |
| US20090082249A1 (en) * | 2005-04-21 | 2009-03-26 | N.V. Nutricia | Nutritional supplement for a category of hiv patients |
| US20080171720A1 (en) * | 2005-04-21 | 2008-07-17 | N.V. Nutricia | Nutritional Supplement For Hiv Patients |
| US20110236500A1 (en) * | 2005-04-21 | 2011-09-29 | N.V. Nutricia | Nutritional supplement with colostrum and epa or dha or gla |
| EP1714562A1 (en) * | 2005-04-22 | 2006-10-25 | N.V. Nutricia | Process for drying uronic acid oligosaccharides |
| WO2006112718A2 (en) * | 2005-04-22 | 2006-10-26 | N.V. Nutricia | Process for drying uronic acid oligosaccharides |
| US20080193627A1 (en) * | 2005-04-22 | 2008-08-14 | N.V. Nutricia | Process For Drying Uronic Acid Oligosaccharides |
| US8048997B2 (en) | 2005-04-22 | 2011-11-01 | N.V. Nutricia | Process for drying uronic acid oligosaccharides |
| WO2006112718A3 (en) * | 2005-04-22 | 2007-03-29 | Nutricia Nv | Process for drying uronic acid oligosaccharides |
| GB2430881A (en) * | 2005-10-06 | 2007-04-11 | Ntnu Technology Transfer As | Use of an oligoelectrolyte polyol to treat mucosal hyperviscosity |
| GB2430881B (en) * | 2005-10-06 | 2010-10-13 | Ntnu Technology Transfer As | Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity |
| US20090156549A1 (en) * | 2005-10-06 | 2009-06-18 | Ntnu Technology Transfer As | Mucosal treatment |
| US8754063B2 (en) | 2005-10-06 | 2014-06-17 | NTNU Technology Transfers AS | Use of oligouronates for treating mucus hyperviscosity |
| US8673878B2 (en) | 2005-10-06 | 2014-03-18 | Ntnu Technology Transfer As | Mucosal treatment |
| US20090010914A1 (en) * | 2005-10-06 | 2009-01-08 | Ntnu Technology Transfer As | Use of Oligouronates for Treating Mucus Hyperviscosity |
| WO2007046697A1 (en) * | 2005-10-21 | 2007-04-26 | N.V. Nutricia | Method for treating and/or preventing infections in infants delivered via caesarean section |
| US8715769B2 (en) | 2005-10-21 | 2014-05-06 | N.V. Nutricia | Preventing diseases in infants delivered via caesarean section |
| US9107438B2 (en) | 2005-10-21 | 2015-08-18 | N.V. Nutricia | Preventing diseases in infants delivered via caesarean section |
| US20090263537A1 (en) * | 2005-10-21 | 2009-10-22 | Joachim Schmitt | Method for stimulating intestinal barrier integrity after non-natural birth |
| US9585416B2 (en) | 2005-10-21 | 2017-03-07 | N.V. Nutricia | Preventing diseases in infants delivered via caesarean section |
| US9596876B2 (en) | 2005-10-21 | 2017-03-21 | N. V. Nutricia | Method for stimulating the intestinal flora |
| US20090162323A1 (en) * | 2005-10-21 | 2009-06-25 | N.V. Nutricia | Method for Stimulating the Intestinal Flora |
| WO2007067033A1 (en) * | 2005-12-06 | 2007-06-14 | N.V. Nutricia | Composition containing oligosaccharides for the treatment/ prevention of infections |
| WO2007067053A1 (en) * | 2005-12-06 | 2007-06-14 | N.V. Nutricia | Composition containing oligosaccharides for the treatment / prevention of infections |
| US20090156550A1 (en) * | 2005-12-06 | 2009-06-18 | Potappel-Van T Land Belinda | Composition containing oligosaccharides for the treatment/prevention of infections |
| AU2006323322B2 (en) * | 2005-12-06 | 2012-08-09 | N.V. Nutricia | Composition containing oligosaccharides for the treatment / prevention of infections |
| US8841279B2 (en) | 2007-04-12 | 2014-09-23 | Norwegian University Of Science And Technology | Oligo-guluronate and galacturonate compositions |
| US20100152122A1 (en) * | 2007-04-12 | 2010-06-17 | Ntnu Technology Transfer As | Oligo-guluronate and galacturonate compositions |
| US8680072B2 (en) | 2007-11-27 | 2014-03-25 | Algipharma As | Use of alginate oligomers in combating biofilms |
| US10624920B2 (en) | 2007-11-27 | 2020-04-21 | Algipharma As | Use of alginate oligomers in combating biofilms |
| US9877983B2 (en) | 2007-11-27 | 2018-01-30 | Algipharma As | Use of alginate oligomers in combating biofilms |
| US20100305062A1 (en) * | 2007-11-27 | 2010-12-02 | Algipharma Ipr As | Use of alginate oligomers in combating biofilms |
| US20110038982A1 (en) * | 2007-12-05 | 2011-02-17 | N.V. Nutricia | High energy liquid enteral nutritional composition |
| US8409651B2 (en) | 2007-12-05 | 2013-04-02 | N. V. Nutricia | High energy liquid enteral nutritional composition |
| US9345256B2 (en) | 2007-12-05 | 2016-05-24 | N.V. Nutricia | High energy liquid enteral nutritional composition |
| US20110008485A1 (en) * | 2007-12-05 | 2011-01-13 | N.V. Nutricia | Protein-dense micellar casein-based liquid enteral nutritional composition |
| US8999423B2 (en) | 2007-12-05 | 2015-04-07 | N. V. Nutricia | High energy liquid enteral nutritional composition |
| US20110021421A1 (en) * | 2007-12-05 | 2011-01-27 | N.V. Nutricia | Liquid enteral nutritional composition with a low specific protein volume |
| US20110077189A1 (en) * | 2008-02-01 | 2011-03-31 | N.V. Nutricia | Composition for stimulating natural killer cell activity |
| US8815797B2 (en) | 2008-03-12 | 2014-08-26 | N.V. Nutricia | High protein liquid enteral nutritional composition |
| US20110046048A1 (en) * | 2008-03-12 | 2011-02-24 | N.V. Nutricia | High protein liquid enteral nutritional composition |
| US9420816B2 (en) | 2008-03-12 | 2016-08-23 | N.V. Nutricia | High protein liquid enteral nutritional composition |
| US20110150851A1 (en) * | 2008-06-30 | 2011-06-23 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
| US8529890B2 (en) | 2009-03-23 | 2013-09-10 | Ntnu Technology Transfer As | Composition for the administration of polymeric drugs |
| US8987215B2 (en) | 2009-03-23 | 2015-03-24 | Ntnu Technology Transfer As | Composition for use in gene therapy |
| US8815831B2 (en) | 2009-06-03 | 2014-08-26 | Algipharma As | Treatment of Acinetobacter with alginate oligomers and antibiotics |
| US9801901B2 (en) | 2009-06-03 | 2017-10-31 | Algipharma As | Alginate oligomers for use in overcoming multidrug resistance in bacteria |
| US9018158B2 (en) | 2009-06-03 | 2015-04-28 | Algipharma As | Alginate oligomers for use in overcoming multidrug resistance in bacteria |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7919479B2 (en) | Antiadhesive carbohydrates | |
| JP5898171B2 (ja) | 炭水化物混合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: N.V. NUTRICIA, NETHERLANDS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:STAHL, BERND;BOEHM, GUNTHER;REEL/FRAME:013322/0084;SIGNING DATES FROM 20020801 TO 20020805 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |